Core Viewpoint - The established domestic cosmetics brand, Chando, is preparing for an IPO in Hong Kong amid the rising trend of "national beauty brands" in the consumer market, but faces challenges such as unstable profitability and declining R&D investment [1][12]. Financial Performance - Chando's revenue for the years 2022 to 2025 (first half) is reported as 4.292 billion, 4.442 billion, 4.601 billion, and 2.448 billion respectively, with 90% of its revenue dependent on the single brand "Chando" [2]. - The net profit figures for the same period are 139 million, 302 million, 190 million, and 191 million, with the first half of 2025 already exceeding the full-year profit of 2024 [2]. R&D Investment - R&D expenditures have decreased over the years, with amounts of 120 million, 93.82 million, 91.21 million, and 42.38 million reported, leading to a declining R&D expense ratio from 2.8% in 2022 to 1.7% in the first half of 2025, which is significantly lower than peers [3][4]. Employee Structure - As of June 30, 2025, Chando has a total of 2,102 employees, with only 154 in R&D, making up 7.3% of the workforce, while administrative staff constitute 8.8% [5]. Consumer Complaints - Chando has received 1,144 complaints on the Black Cat Complaints platform, primarily related to issues such as price discrepancies, allergic reactions, and poor customer service [6][7]. - Complaints include specific cases of unfulfilled promises regarding price guarantees and missing items in orders, indicating potential issues in customer service and fulfillment [6][7]. Market Position and Strategy - The Chinese cosmetics market is the second largest globally, with a projected growth from 779.4 billion in 2019 to 934.6 billion by 2024, reflecting a compound annual growth rate of 3.7% [9]. - Chando's strategy appears conservative, with indications that it may not pursue aggressive expansion or acquisitions due to the associated risks and challenges [10][11][12].

Core Viewpoint - The well-known domestic beauty brand, Chando, has initiated its IPO process, marking a significant step towards its market expansion despite recent underwhelming performance in revenue growth and profitability [1][4]. Group 1: Financial Performance - In 2024, Chando reported a revenue of 4.601 billion yuan, reflecting a year-on-year growth of 3.58%, while its net profit decreased by nearly 40% to 190 million yuan [2][5]. - Chando's revenue is significantly lower compared to its competitors, with Proya and Shiseido achieving revenues of 10.778 billion yuan and 6.793 billion yuan respectively in 2024 [2][5]. - Chando's revenue in 2024 was approximately 80% of Beitaini's revenue, which reached 5.7 billion yuan [6]. Group 2: Online Channel Transformation - Chando's slow transition to online sales channels is a critical factor in its performance, with online sales accounting for less than 70% of its revenue, compared to over 80% for Proya [3][10]. - The online channel's contribution to Chando's revenue increased from 59.7% in 2022 to 68.8% in 2024, indicating a gradual but insufficient shift [10]. - In contrast, Proya's online revenue share surged from 70.01% in 2020 to 93.07% in 2023, showcasing a successful adaptation to market changes [8]. Group 3: Marketing and Brand Strategy - Chando has invested heavily in marketing, with total expenditures reaching 7.568 billion yuan from 2022 to 2024, which is significantly higher than the industry average [3][21]. - The marketing expense ratio for Chando was 59% in 2024, compared to an average of 47.78% for its peers, indicating a higher cost burden [21][23]. - Chando is focusing on launching new brands to drive growth, with the brand "Pofenyan" showing promising results, generating 121 million yuan in revenue in 2024, a growth of over 90% [20]. Group 4: Future Outlook - Chando plans to enhance its marketing efforts through collaborations with KOLs and increased advertising on major e-commerce and social media platforms [23]. - The company aims to open more offline flagship stores to strengthen its market presence, with new stores planned in major cities [13][16]. - The effectiveness of Chando's marketing investments and its ability to adapt to changing consumer preferences will be crucial for its future growth [23].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry [2]. Core Views - The cosmetics and medical beauty sector has shown stronger performance than the market, with the Shenwan Beauty Care Index declining by 2.5% from October 10 to October 17, 2025, which is better than the overall market performance [4][5]. - The Tmall Double 11 event has seen significant success for domestic brands, with brands like Maogeping experiencing high demand and sold-out products [10]. - The overall performance for Q3 2025 is expected to meet expectations, with a continued upward trend into Q4, driven by promotional events [11][12]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector outperformed the market during the specified period, with the Shenwan Cosmetics Index down by 1.1%, which is 2.3 percentage points better than the Shenwan A Index [4][5]. - Key stocks in the sector included Jiaheng Jiahua (+35.0%), Yiyi Co. (+18.6%), and Yanjing Co. (+15.6%) [6]. Market Trends - The Tmall Double 11 event on October 15 attracted over 10 million viewers, with domestic brands like Maogeping experiencing supply shortages due to high demand [10]. - The overall sales performance is expected to improve in the coming weeks, particularly with the upcoming Douyin Double 11 event [10]. Q3 Performance Outlook - The demand for cosmetics remains robust, with retail sales growth in July and August outpacing the overall market [11]. - The total retail sales of cosmetics for the first eight months of 2025 reached 291.5 billion yuan, a year-on-year increase of 3.3% [11]. - Domestic brands are leveraging online channels effectively, with Han Shu achieving over 2 billion yuan in GMV in Q3 [12]. Company Highlights - Han Shu announced a global partnership with Wang Jiaer, enhancing its international presence and brand recognition [19][22]. - The report recommends focusing on companies with strong channel and brand matrices, such as Maogeping, Shanghai Jahwa, and Up Beauty [14]. E-commerce Data - The report highlights significant growth in e-commerce sales for various brands, with Han Shu achieving a 37% increase in GMV [15]. - The overall e-commerce landscape for domestic brands is expected to continue thriving, supported by promotional events and strategic partnerships [15][18]. Market Dynamics - The report notes that the Chinese skincare market is projected to reach 271.2 billion yuan in 2024, despite a slight decline in growth [26]. - Domestic brands are increasingly capturing market share, with a notable presence in the top ten rankings [26][27]. Investment Recommendations - The report suggests investing in companies with strong growth potential and robust product pipelines, particularly in the cosmetics and medical beauty sectors [14]. - Specific recommendations include Maogeping, Up Beauty, and Shanghai Jahwa for cosmetics, and Aimeike for medical beauty [14].

Core Viewpoint - The news highlights the IPO application of CHANDO, a well-established Chinese beauty brand, aiming to enter the Hong Kong stock market with a valuation exceeding 7.1 billion RMB, backed by significant investments from L'Oréal and other capital firms [3][5][6]. Company Overview - CHANDO has been in operation for 25 years and is now the third-largest domestic cosmetics group in China, with annual revenues exceeding 4.5 billion RMB [4][7]. - The company has a diverse brand portfolio, including CHANDO, Biorrier, MAYSU, SPRING SUNMER, and others, covering various product categories such as skincare, makeup, and personal care [7][8]. - The flagship brand, CHANDO, has consistently contributed over 94% of the company's total revenue from 2022 to 2025 [7][11]. Financial Performance - Revenue figures for CHANDO from 2022 to 2025 are projected to be 42.92 billion RMB, 44.42 billion RMB, and 46.01 billion RMB, with a significant increase in gross margin from 66.5% in 2022 to 70.1% in the first half of 2025 [7][11]. - The company has a registered membership of 37.7 million, with a repurchase rate of 32.4%, indicating a stable customer base [8]. Investment Backing - L'Oréal invested 442 million RMB and Cahua Capital invested 300 million RMB in CHANDO, holding 6.67% and 4.20% of shares, respectively, leading to a pre-IPO valuation exceeding 7.1 billion RMB [6][10]. Market Position and Challenges - The beauty industry in China is highly fragmented, with the top five domestic cosmetics groups holding only about 10.1% market share, indicating a low concentration [11]. - CHANDO's revenue growth rate of 3.6% for 2024 is significantly lower than competitors like Mao Geping and Lin Qingxuan, which have higher growth rates [11]. - The brand's international recognition and market share are limited, with a need to leverage L'Oréal's backing to expand overseas [11][12]. Industry Trends - The domestic beauty market is evolving, with Chinese brands capturing approximately 55.2% market share by 2024, reflecting a growing preference for local products among consumers [12]. - The competition is intensifying, with brands focusing on research and development, emphasizing patent acquisition and scientific investment [12].

Core Viewpoint - Natural Hall, a well-established Chinese cosmetics brand, has submitted its IPO application to the Hong Kong Stock Exchange, aiming for a valuation exceeding 7.1 billion RMB, backed by investments from major players like L'Oréal and China Capital [1][4]. Company Overview - Founded 25 years ago, Natural Hall has become the third-largest domestic cosmetics group in China, with annual revenues exceeding 4.5 billion RMB as of 2024 [3]. - The company has a diverse brand portfolio, including Natural Hall, Biorrier, MAYSU, Spring Summer, and GB, covering various product categories such as skincare, makeup, and personal care [5][6]. Financial Performance - Revenue figures for Natural Hall from 2022 to 2025 are projected as follows: 42.92 billion RMB in 2022, 44.42 billion RMB in 2023, and 46.01 billion RMB in 2024, with 24.48 billion RMB in the first half of 2025 [5]. - The gross profit margin has shown a steady increase, from 66.5% in 2022 to 70.1% in the first half of 2025 [5]. Investment Backing - The IPO is supported by significant investments from L'Oréal (442 million RMB) and China Capital (300 million RMB), which hold 6.67% and 4.20% of the company, respectively [4][5]. Market Position and Challenges - Natural Hall's market share is under pressure from competitors, with the top five domestic cosmetics groups holding only about 10.1% of the market share as of 2024 [11]. - The company faces challenges in revenue growth, with a projected growth rate of only 3.6% for 2024, significantly lower than competitors like Mao Ge Ping and Lin Qingxuan [11][12]. Brand Recognition and Customer Base - Natural Hall has a stable customer base, with 37.7 million registered members and a repurchase rate of 32.4% [7]. - The flagship brand, Natural Hall, consistently contributes over 94% of the company's total revenue from 2022 to 2025 [5][12]. Future Outlook - The IPO represents a strategic move for Natural Hall to strengthen its position in the competitive beauty market and potentially expand its presence in overseas markets, leveraging L'Oréal's endorsement [11][14]. - The company is entering a phase of heightened competition, with a focus on research and development becoming crucial for survival and growth in the evolving beauty industry [14].

Core Viewpoint - The recent IPO application by Naturando Global Holdings Limited marks a significant move in the Chinese beauty market, reflecting both the company's ambition to prove its strength in the capital market and the competitive pressures faced by mid-tier beauty brands in a saturated market [1][6]. Company Overview - Naturando, established 25 years ago, has submitted its IPO application to the Hong Kong Stock Exchange with a valuation exceeding 7.1 billion RMB, backed by investments from L'Oréal (442 million RMB) and Cahua Capital (300 million RMB) [1][2]. - The company has positioned itself as the third-largest domestic cosmetics group in China, with annual revenues exceeding 4.5 billion RMB [1][3]. Financial Performance - Naturando's revenue figures for 2022 to 2024 are reported as 42.92 billion RMB, 44.42 billion RMB, and 46.01 billion RMB, with a revenue of 24.48 billion RMB in the first half of 2025 [3]. - The gross profit margins have shown a steady increase, from 66.5% in 2022 to 70.1% in the first half of 2025 [3]. Brand Portfolio - The company has developed a diverse brand portfolio, including Naturando, Pofuyan, Chunsummer, Meisu, and Jichu, covering various categories such as skincare, makeup, personal care, men's grooming, and children's care [3]. - Naturando remains the most recognized brand, contributing over 94% of total revenue from 2022 to 2025 [3]. Shareholding Structure - The Zheng family, as the founders, have structured the shareholding to protect their interests, with a complex offshore holding setup ensuring control over the company [4][5]. Market Position and Competition - The beauty industry in China is highly fragmented, with the top five domestic cosmetics groups holding only about 10.1% market share, indicating low concentration [7]. - Naturando's revenue growth rate of 3.6% for 2024 is significantly lower than competitors like Mao Geping and Lin Qingxuan, highlighting the need for enhanced growth strategies [7]. Industry Trends - The domestic beauty market is experiencing a shift, with local brands capturing approximately 55.2% market share by 2024, indicating a growing preference for domestic products among consumers [8]. - The competition is intensifying, with brands engaging in a "scientific arms race" to enhance their research and development capabilities, which is crucial for capital investment [8].

Core Viewpoint - The company, Chando, is preparing for an IPO after 24 years in the beauty industry, marking a significant shift as it brings in external investors like L'Oréal and Cathay Capital for the first time [1][9]. Company Background - Chando was founded by Zheng Chunying in 2001, initially starting with two brands, Chando and Meisu, and gradually expanding into skincare, makeup, and maternal and infant care [5]. - The Zheng family maintains significant control over the company, with a combined stake of nearly 87% before the IPO [7]. Financial Performance - Revenue is projected to grow from 42.92 billion RMB in 2022 to 46.01 billion RMB in 2024, with 24.48 billion RMB reported in the first half of 2025 [13]. - The gross profit margin has been increasing, surpassing 70.1% in the first half of 2025 [13]. Research and Marketing Discrepancies - Research and development (R&D) spending from 2022 to June 2025 totaled 3.48 billion RMB, with the R&D expense ratio declining from 2.8% to 1.7%, while marketing expenses remained high at 54% to 59% [15]. - The company has faced challenges in adapting to consumer demands for ingredient transparency and efficacy, falling behind competitors like Winona and Proya [18]. Brand and Channel Dependency - Chando heavily relies on its single brand, which accounted for approximately 95% of its revenue from 2022 to the first half of 2025, with other brands contributing only 5% [20]. - The online sales ratio increased from 59.7% in 2022 to 68% in the first half of 2025, but still lags behind competitors like Proya, which has nearly 95% online sales [22]. Strategic Recommendations - The company needs to transform its offline channels from mere sales points to experiential zones, enhancing customer engagement through in-store experiences [26]. - Learning from competitors like Proya, which successfully integrates online live streaming with offline pop-up stores, could help Chando attract more traffic and improve customer experience [28].

Core Insights - The article discusses the IPO of Chando, a leading Chinese beauty brand, which marks a significant step in its capital journey after over 20 years in the market [1] - Chando has evolved from a channel-focused brand to one that aims for digital and refined management, seeking to establish a strong foothold in the competitive beauty market [6][12] Group 1: Company History and Development - Chando was founded in 2001, capitalizing on the gap in the Chinese cosmetics market, particularly in the CS channel [2] - The brand quickly became a leader in the CS channel, achieving significant growth and establishing itself as a benchmark for domestic products [2][3] - By 2010, Chando had successfully entered over 2,600 supermarkets, solidifying its position as a "national brand benchmark" [3] Group 2: Financial Performance - Chando's revenue has shown steady growth, with projected revenues of 42.92 billion, 44.42 billion, and 46.01 billion CNY from 2022 to 2024, and 24.48 billion CNY in the first half of 2025, reflecting a 6.4% year-on-year increase [6][7] - Despite a gross margin increase from 66.5% in 2022 to 70.1% in the first half of 2025, its net profit has fluctuated, with figures of 1.39 billion, 3.02 billion, and 1.90 billion CNY from 2022 to 2024 [7] - Chando's compound annual growth rate from 2022 to 2025 is only 3.5%, which is below the industry average, indicating challenges in maintaining competitive growth [7][10] Group 3: Market Position and Challenges - Chando's reliance on a single brand for over 94% of its revenue poses risks, especially as competitors leverage multi-brand strategies to capture diverse consumer segments [10] - The company has faced challenges in balancing marketing and R&D investments, with marketing expenses significantly outpacing R&D spending [10][11] - The competitive landscape is intensifying, with other brands achieving higher growth rates, highlighting Chando's need for strategic adjustments [7][10] Group 4: Future Prospects and Strategic Moves - The recent IPO and investment from L'Oréal are seen as pivotal for Chando, providing opportunities to enhance DTC capabilities, expand brand offerings, and increase R&D investments [11][12] - L'Oréal's involvement is expected to bolster Chando's product development and international expansion efforts, potentially leading to a more resilient brand ecosystem [11][12] - The company aims to address its growth uncertainties by diversifying its brand portfolio and improving its R&D focus, which are critical for long-term competitiveness [12]

Core Viewpoint - The article discusses the upcoming IPO of China's beauty brand "Chando" and its significance in the market, highlighting its growth and the strategic moves made by its parent company, Jala Group, led by founder Zheng Chunying [1][4]. Group 1: Company Overview - Chando, a leading Chinese beauty brand, has applied for a listing on the Hong Kong Stock Exchange, with Huatai International and UBS serving as joint sponsors [1]. - Founded by Zheng Chunying in 2001, Chando has expanded its presence across China, with over 62,700 retail points and more than 45,000 stores nationwide [5]. - The company operates a multi-brand matrix, including Chando, Pechoin, Meisu, and others, covering skincare, makeup, and personal care products [5]. Group 2: Financial Performance - Chando's revenue has shown consistent growth, with figures of 4.292 billion yuan, 4.442 billion yuan, 4.601 billion yuan, and 2.448 billion yuan for the years 2022 to the first half of 2025, respectively, with a year-on-year growth of 6.4% in the first half of 2025 [5][6]. - The company's net profit for the same periods was 139 million yuan, 302 million yuan, 190 million yuan, and 191 million yuan, indicating a stable profit trajectory [5]. Group 3: Market Position and Strategy - Chando ranks as the third-largest domestic cosmetics group in China by retail sales in 2024, with its brand being the second-largest among domestic brands, following Pechoin [5]. - The growth in revenue is attributed to the expansion of online channels, with online sales increasing from 59.7% in 2022 to 68.8% in the first half of 2025 [6]. - The company aims to enhance its direct-to-consumer (DTC) capabilities and improve the synergy between online and offline sales networks through the funds raised from the IPO [10]. Group 4: Ownership and Corporate Structure - Zheng Chunying and family hold approximately 87.82% of the voting rights in Chando, following a red-chip restructuring to facilitate the IPO [9]. - The company has a strategic partnership with L'Oréal, which holds a 6.67% stake in Chando [10].

Core Viewpoint - Chando Global Holdings Limited, a Chinese beauty unicorn, has applied for a listing on the Hong Kong Stock Exchange, marking a significant milestone for the company and its founder, Zheng Chunying, after 24 years in the capital market [1][3]. Group 1: Company Overview - Founded in 2001 by Zheng Chunying, Chando has grown from a beauty chain in Northeast China to a major player in the beauty industry, launching brands like "Meisu" and flagship brand "Chando" [3]. - Chando has established a multi-brand matrix, including five main brands: Chando, Peffy, Meisu, Chunxia, and Jichu, covering skincare, color cosmetics, and personal care categories [3]. - As of 2024, Chando is the third-largest domestic cosmetics group in China by retail sales, with its single brand ranking second among domestic brands, just below Pechoin [3]. Group 2: Financial Performance - Chando's revenue has shown consistent growth, with reported revenues of 4.292 billion, 4.442 billion, 4.601 billion, and 2.448 billion yuan for the years 2022 to 2025 H1, respectively, with a year-on-year growth of 6.4% in the first half of 2025 [3][4]. - The net profit for the same periods was 139 million, 302 million, 190 million, and 191 million yuan, indicating a stable profit trajectory [3]. Group 3: Market Position and Strategy - The growth in revenue is primarily attributed to the expansion of online channels and an increase in the number of offline retailers, with online revenue share rising from 59.7% in 2022 to 68.8% in the first half of 2025 [4]. - Chando's gross margin improved from 66.5% to 70.1%, although it remains lower than some high-end competitors, indicating potential for further premiumization [4]. Group 4: IPO and Future Plans - The IPO proceeds will be used to enhance direct-to-consumer capabilities, improve online and offline sales synergy, expand the multi-brand matrix, invest in R&D, and strengthen digital capabilities in membership, supply chain, and sales management [7]. - The company aims to enhance its production facilities and expand its international market presence to increase brand recognition and penetration [7].